E-LIB Suche - Ergebnisse für: Nathan, Pradeep J

1

A phase 1b/2a multicenter study of the safety and prelimina..:

Nathan, Pradeep J. ; Millais, S. Babli ; Godwood, Alex...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

2

Cognitive Go/No-Go decision-making criteria in Alzheimer's ..:

Wessels, Alette M. ; Edgar, Chris J. ; Nathan, Pradeep J....
Drug Discovery Today. 26 (2021) 5 - p. 1330-1336 , 2021

Link: https://doi.org/10.1016/..

3

First‐in‐man study to investigate safety, pharmacokinetics ..:

Bakker, Charlotte ; Tasker, Tim ; Liptrot, Jan...
British Journal of Clinical Pharmacology. 87 (2021) 7 - p. 2945-2955 , 2021

Link: https://doi.org/10.1111/..

4

Acetylcholine prioritises direct synaptic inputs from entor..:

Palacios-Filardo, Jon ; Udakis, Matt ; Brown, Giles A....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

5

Author Correction: Acetylcholine prioritises direct synapti..:

Palacios-Filardo, Jon ; Udakis, Matt ; Brown, Giles A....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

6

Safety, pharmacokinetics and exploratory pro-cognitive effe..:

Bakker, Charlotte ; Tasker, Tim ; Liptrot, Jan...
Alzheimer's Research & Therapy. 13 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Safety, pharmacokinetics and pharmacodynamics of HTL0009936..:

Bakker, Charlotte ; Prins, Samantha ; Liptrot, Jan...
British Journal of Clinical Pharmacology. 87 (2021) 11 - p. 4439-4449 , 2021

Link: https://doi.org/10.1111/..

8

Spatial Covariance of Cholinergic Muscarinic M1/M4 Receptor..:

Colloby, Sean J. ; Nathan, Pradeep J. ; Bakker, Geor...
Movement Disorders. 36 (2021) 8 - p. 1879-1888 , 2021

Link: https://doi.org/10.1002/..

9

From structure to clinic: Design of a muscarinic M1 recepto..:

Brown, Alastair J.H. ; Bradley, Sophie J. ; Marshall, Fiona H....
Cell. 184 (2021) 24 - p. 5886-5901.e22 , 2021

Link: https://doi.org/10.1016/..

10

Lessons learned from using fMRI in the early clinical devel..:

Nathan, Pradeep J. ; Bakker, Geor
Psychopharmacology. 238 (2020) 5 - p. 1255-1263 , 2020

Link: https://doi.org/10.1007/..

11

Cholinergic muscarinic M1/M4 receptor networks in dementia ..:

Colloby, Sean J ; Nathan, Pradeep J ; McKeith, Ian G...
Brain Communications. 2 (2020) 2 - p. , 2020

Link: https://doi.org/10.1093/..

12

P3‐100: CH 1,2, AND 3 BASAL FOREBRAIN NUCLEI VOLUMES PREDIC..:

Nathan, Pradeep J. ; Bakker, Geor ; Godwood, Alex...
Alzheimer's & Dementia. 15 (2019) 7S_Part_18 - p. , 2019

Link: https://doi.org/10.1016/..

13

P3‐025: USE OF A MODIFIED HIDDEN PATHWAY MAZE TEST IN PATIE..:

Edgar, Chris J. ; Tasker, Tim ; Schembri, Adrian...
Alzheimer's & Dementia. 15 (2019) 7S_Part_18 - p. , 2019

Link: https://doi.org/10.1016/..

14

Cholinergic muscarinic M1 and M4 receptors as therapeutic t..:

Erskine, Daniel ; Taylor, John-Paul ; Bakker, Geor...
Drug Discovery Today. 24 (2019) 12 - p. 2307-2314 , 2019

Link: https://doi.org/10.1016/..

15

The effects of GSK2981710, a medium‐chain triglyceride, on ..:

O'Neill, Barry V. ; Dodds, Chris M. ; Miller, Sam R....
Human Psychopharmacology: Clinical and Experimental. 34 (2019) 3 - p. , 2019

Link: https://doi.org/10.1002/..